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Ataxin-3, the protein responsible for spinocerebellar ataxia type-3, is a cysteine protease
that specifically cleaves poly-ubiquitin chains and participates in the ubiquitin proteasome
pathway. The enzymatic activity resides in the N-terminal Josephin domain. An unusual
feature of ataxin-3 is its low enzymatic activity especially for mono-ubiquitinated
substrates and short ubiquitin chains. However, specific ubiquitination at lysine 117 in the
Josephin domain activates ataxin-3 through an unknown mechanism. Here, we investigate
the effects of K117 ubiquitination on the structure and enzymatic activity of the protein.
We show that covalently linked ubiquitin rests on the Josephin domain, forming a compact
globular moiety and occupying a ubiquitin binding site previously thought to be essential
for substrate recognition. In doing so, ubiquitination enhances enzymatic activity by locking
the enzyme in an activated state. Our results indicate that ubiquitin functions both as a
substrate and as an allosteric regulatory factor. We provide a novel example in which a
conformational switch controls the activity of an enzyme that mediates deubiquitination.
Keywords: ataxin-3, SCA3, polyglutamine disease, deubiquitinating enzyme, cysteine protease, ubiquitin,
structure
INTRODUCTION
Protein ubiquitination is a reversible post-translational modifi-
cation that regulates several crucial intracellular events ranging
from signaling pathways to cell cycle regulation and DNA repair
(Hershko and Ciechanover, 1998). It involves the covalent attach-
ment of the C-terminal glycine of ubiquitin to a lysine of the tar-
get protein through an isopeptide bond. Proteins can be mono-,
multi- or poly-ubiquitinated. Ubiquitin itself has seven lysines
plus the N-terminal amino group, which can be involved in the
formation of isopeptide bonds to form poly-ubiquitin chains.
Among the different chain types, K48-linked and K63-linked
chains are the most studied and are linked respectively to pro-
tein degradation and to endocytotic trafficking, translation and
inflammatory events (Thrower et al., 2000; Chen and Sun, 2009).
Ubiquitin signaling is regulated by numerous ubiquitin ligases
(E3) and deubiquitinating enzymes (DUB) that have quite differ-
ent properties and substrate specificities (Ardley and Robinson,
2005; Komander et al., 2009).
A DUB that has attracted particular interest in recent years
is ataxin-3, an enzyme with interesting yet still elusive prop-
erties. Ataxin-3 is responsible for the neurodegenerative dis-
order Spinocerebellar ataxia type 3 (SCA3), also known as
Machado-Joseph disease (Paulson, 2012), which is the most
common dominantly inherited ataxia and a member of the
polyglutamine disease family (Kawaguchi et al., 1994;Matos et al.,
2011). Ataxin-3 contains an N-terminal globular domain named
Josephin, in which the enzymatic catalytic triad resides, and
an intrinsically unfolded C-terminus that contains the polyg-
lutamine tract and two or three ubiquitin interacting motifs
(UIMs) depending on the isoform (Scheme 1 in Supplementary
Material) (Masino et al., 2003). Josephin is a cysteine protease
which preferentially cleaves ubiquitin chains with five or more
repeats (Albrecht et al., 2004; Chai et al., 2004; Costa et al.,
2004; Rodrigues et al., 2007). The full-length protein has pref-
erence for K63 linkages (Burnett et al., 2003; Chow et al., 2004;
Weeks et al., 2011) or for K48/K63-linked poly-ubiquitin chains
(Winborn et al., 2008; Todi et al., 2009), whereas the isolated
Josephin domain cleaves more efficiently K48 chains (Todi et al.,
2009).
The Josephin domain of ataxin-3 is unusual in several respects.
Despite the typical cysteine protease fold, it contains an unusually
long helical hairpin not observed in other cysteine proteases (such
as papain) or in other DUBs (for example YUH1 or UCH-L3)
(Nicastro et al., 2005) (Scheme 1 in Supplementary Material). It
also contains at least two binding sites for ubiquitin in addition to
the multiple UIMs in the C-terminus of ataxin-3. Ubiquitin bind-
ing site 1 is essential for enzymatic activity (Nicastro et al., 2010)
while site 2 confers K48 ubiquitin-chain linkage preference to
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Josephin and overlaps with the interaction site for the ubiquitin-
like domain of the HHR23 proteins (Nicastro et al., 2005, 2010).
The interaction of site 2 with HHR23A/B was recently shown to
regulate the cellular turnover of this protein (Blount et al., 2014).
Previous measurements strongly suggest that a flexible helical
hairpin separating the two binding sites plays a role in ubiqui-
tin recognition and possibly determines substrate and ubiquitin
linkage specificity (Nicastro et al., 2005, 2010).
An important open question concerns ataxin-3 enzymatic
properties. Except to longer poly-ubiquitin chains, the prote-
olytic activity of ataxin-3 is markedly lower than most other DUB
enzymes. It has been shown, however, that mono-ubiquitination
has some effect in activating the enzyme (Todi et al., 2009). Lysine
117 of the Josephin domain is the preferential ubiquitination site,
with mono-ubiquitination at this site being sufficient to enhance
the DUB activity (Todi et al., 2010). Several E3 ubiquitin lig-
ases (Durcan and Fon, 2013), including the C-terminus of 70kDa
heat-shock protein (Hsp70)-interacting protein (CHIP), parkin,
and E4B, promote ataxin-3 ubiquitination (Matsumoto et al.,
2004; Jana et al., 2005; Miller et al., 2005). Lysine 117 ubiquitina-
tion is also able to suppress expanded polyglutamine-dependent
degeneration in Drosophila melanogaster (Tsou et al., 2013), sug-
gesting that lysine 117 ubiquitination is critical for a putative
neuroprotective role of the protein. Despite increasing interest
in the role of ataxin-3 ubiquitination and in how ubiquitination
may influence DUB activity, little is known about the mechanism
by which this modification leads to enzyme activation. Knowing
this mechanism would increase our understanding of the ubiq-
uitin pathways and provide new information on polyglutamine
expansion diseases that may be translated into specific treatments.
Here, we used complementary biophysical techniques to study
the enzymatic activity of Josephin and the factors influenc-
ing it. We also addressed the role of ubiquitination and its
consequences at the structural level. We exploited for these
studies our recent protocol that allows us to produce highly
pure recombinant Josephin ubiquitinated at K117 in quanti-
ties suitable for structural studies (Faggiano et al., 2013). Our
data provide a completely new understanding of the role of
site 1: binding of covalently linked mono-ubiquitin locks the
enzyme in an active state. Our results provide a structural expla-
nation on how ubiquitination can directly regulate the DUB
activity of ataxin-3 and enable us to propose a general regula-
tory mechanism that can modulate the activity of other such
enzymes.
EXPERIMENTAL PROCEDURES
PROTEIN PRODUCTION
The N-terminal Josephin domain of ataxin-3 (amino acids 1–
182) in which all lysines but K117 were mutated to arginines
(JosK117-only) was produced as previously reported (Todi et al.,
2010; Faggiano et al., 2013). Recombinant wild-type Josephin
was obtained with the same purification method. The W87R
mutant of JosK117-only was prepared by using QuickChange
Site-Directed Mutagenesis kit (Stratagene). E1 from insect cells,
UbcH5a (E2, Addgene plasmid 15782) and CHIP (E3) enzymes
from E. coli expression were all purified by affinity chromatog-
raphy. Recombinant wild-type human ubiquitin was purified by
anion exchange followed by gel filtration. Labeled samples for
nuclear magnetic resonance (NMR) experiments were obtained
by expression in minimal medium containing 15NH4Cl and 13C-
glucose as the sole nitrogen and carbon source.
IN VITRO UBIQUITINATION AND PURIFICATION OF UBIQUITINATED
JOSEPHIN
In vitro ubiquitination was achieved by adapting and scaling up
a previous protocol (Todi et al., 2009), as described in Faggiano
et al. (2013). In short, we lowered the temperature from 37◦C to
25◦C and reduced the salt concentration (i.e., eliminating KCl)
to reduce the risk of Josephin aggregation. The reaction was car-
ried out for 18–20 h using 50μM JosK117-only, 1μM E1, 8μM
UbcH5a, 1μM CHIP, 250μM ubiquitin, 4.5mM ATP-MgCl2, in
buffer 50mMTris pH 7.5, 0.5mMDTT. Themono-ubiquitinated
protein was then purified by anion exchange using a Hi-Trap Q
HP column (GEHealthcare). After a first wash step at 0.1MNaCl,
the protein was eluted with a linear salt gradient (0.1-0.2MNaCl)
in buffer 50mM Tris pH 7.5, 2mM DTT.
CIRCULAR DICHROISM (CD)
Far-UV CD spectra were recorded on a Jasco J-715 spectropo-
larimeter equipped with a Peltier temperature control system.
Samples were prepared in buffer 20mM sodium phosphate pH
6.5, 2mM DTT.
ACTIVITY ASSAYS WITH UB-AMC AND DI-UBIQUITIN
DUB activity was measured using the fluorogenic substrate
7-amino-4-methylcoumarin ubiquitin (Ub-AMC, Boston
Biochem). 1μM Ub-AMC was added to 100 nM protein samples
in buffer 20mM Tris pH 8.0, 0.1% BSA, 1mM DTT. The
concentration of isopeptidase T was 10 nM. Experiments were
performed at 25◦C. Ub-AMC cleavage was monitored as a
function of time measuring the increased fluorescence emission
at 460 nm after excitation at 380 nm. Experiments in the presence
of free ubiquitin were performed in similar conditions, without
adding BSA to the buffer. Cleavage of di-ubiquitin by JosK117-
only and its mono-ubiquitinated form was performed at 25◦C
in 50mM Tris pH 7.5, 0.5mM DTT, using 20μM Josephin and
20μMK48- and K63-linked di-ubiquitin.
NMRMEASUREMENTS
Josephin samples for NMR experiments were prepared in 20mM
Na phosphate, pH 6.5, 2mM DTT at a concentration of 250–
300μM, unless otherwise specified. Measurements were carried
out at 25◦C on Bruker 600 and 700 MHz, and Varian INOVA
800 MHz instruments. Backbone assignment for JosK117-only
was obtained by HNCACB and CBCA(CO)NH triple resonance
3D experiments. HNCA and HN(CO)CA experiments were used
for ubiquitinated JosK117-only. The assignment of 15N labeled
ubiquitin linked to K117 on Josephin was performed by compar-
ison with the 3D 15N-NOESY HSQC of free ubiquitin. Chemical
shift perturbation (CSP) analysis of the changes occurring upon
ubiquitination was carried out applying the following formula:
δavg = {1/2[δ2NH + (0.2δN)2]}1/2. Relaxation experiments
(15N T1, T2 and heteronuclear NOEs) were acquired at 700MHz.
Relaxation delays of 10, 100, 200, 400, 700, 1100, 1400, and 16, 32,
48, 63, 79, 111, 152ms were used for T1 and T2 measurements,
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respectively. Data analysis was performed excluding overlapping
resonances. Titrations with unlabeled ubiquitin were performed
recording 15N HSQC spectra of 100μM Josephin samples up to
9 equivalents of ubiquitin. 15N ubiquitin (50μM) was titrated
with JosK117-onlyW87R and its mono-ubiquitinated form to a
maximum ratio of 2 equivalents. Cross-saturation experiments
were performed at 800 MHz on perdeuterated 15N JosK117-only
and on the same protein covalently attached to unlabeled ubiq-
uitin on K117. Data were acquired at three different saturation
times (0.5, 1.0, and 1.5 s). Protein concentration was 210μM
for JosK117-only and 230μM for ubiquitinated JosK117-only.
A 3D 15N-edited NOESY-HSQC (mixing time 0.1 s) carried out
at 600 MHz on a 2H,15N labeled mono-ubiquitinated JosK117-
only sample (labeled JosK117-only covalently linked to unla-
beled ubiquitin) was used to determine intermolecular distances.
The intermolecular peaks were assigned using as a reference
the 15N-edited NOESY-HSQC of mono-ubiquitinated JosK117-
only, obtained using 15N labeled ubiquitin linked to unlabeled
Josephin.
STRUCTURE CALCULATIONS
The structure of JosK117-only was initially homology modeled
on the basis of the crystal structure of the Josephin compo-
nent of ATXN3L in complex with ubiquitin (3O65) and ener-
getically minimized using the module Biopolymer of Insight
II (Accelrys, Inc.). The structural coordinates of the model of
JosK117-only and of ubiquitin (PDB file 1UBQ) were used to
build the structure of mono-ubiquitinated Josephin by the dock-
ing software HADDOCK. The covalent bond between Josephin
K117 and ubiquitin G76 was simulated imposing an unambigu-
ous restraint between the lysine amino group and the carbonyl
group of the glycine. For ubiquitin, NMR CSP data were used
to define the “ambiguous interactive restraints” (AIRs) according
to HADDOCK, choosing as “active” all water accessible residues
with δ > 0.1 ppm from the average. Cross-saturation data were
used to define the AIRs for Josephin: we considered as “active”
all water accessible residues with percentage of attenuation >10%
at saturation time of 0.5 s. For both Josephin and ubiquitin, all
solvent accessible surface neighbors of active residues (within a
radius of 6.5 Å) were assigned as “passive” residues. Josephin
residues 52–75 and ubiquitin residues 72–76 were defined as
“fully flexible.” NOEs effects observed in a 15N-edited 3DNOESY-
HSQC were used as additional restraints.
SAXS EXPERIMENTS
Synchrotron radiation X-ray scattering data were collected on
the EMBL P12 beam line at the PETRA III storage ring, DESY,
Hamburg. Solutions of Josephin domain of ataxin-3 were mea-
sured at protein concentrations of 1.1, 2.1, and 4.3 mg/mL
using PILATUS 2M pixel detector (DECTRIS, Switzerland),
sample- detector distance 3.1 m, wavelength λ = 1.25Å, cov-
ering the momentum transfer range 0.003 < s < 0.45Å−1 [s =
4π sin(θ)/λ where 2θ is the scattering angle]. To check for
radiation damage, twenty 50-ms exposures were compared; no
radiation damage effects were observed. The data, after normal-
ization to the intensity of the incident beam, were averaged, and
the scattering of the buffer was subtracted. The difference data
were extrapolated to zero solute concentration following stan-
dard procedures. All data manipulations were performed using
the program package PRIMUS (Konarev et al., 2003). Multiple
runs of the program DAMMIF (Nicastro et al., 2004), a fast
version of DAMMIN (Franke and Svergun, 2009), were used
to produce average low resolution ab initio shape of the com-
plex. Rigid body modeling was performed with the program
SASREF (Petoukhov and Svergun, 2005) using the X-ray struc-
ture of the C14mono-ubiquitinated Josephin complex (PDB code
3O65) and optimizing the orientation/position of the ubiquitin
molecule relative to the Josephin domain without any contact
restraints.
RESULTS
COVALENTLY LINKED UBIQUITIN BINDS TO SITE 1
Wefirst addressed the question of how the covalently bound ubiq-
uitin interacts with Josephin. For our studies we used a Josephin
mutant (JosK117-only), in which all lysines but K117 (i.e., K8,
85, 125, 128, and 166) were mutated to arginines to ensure ubiq-
uitination solely at lysine 117 and sample homogeneity (Todi
et al., 2010). This mutant was used since it is not possible to
generate wild-type mono-ubiquitinated Josephin in vitro because
other lysine residues are also ubiquitinated, albeit at lower fre-
quency than K117 (Todi et al., 2010). As shown elsewhere, these
mutations do not affect protein fold or DUB activity (Todi et al.,
2010; Faggiano et al., 2013). We capitalized on the ability to
produce large quantities of mono-ubiquitinated JosK117-only
using a protocol previously described (Faggiano et al., 2013).
This capability allowed us to exploit the full richness of specific
labeling schemes and use NMR to obtain structural information
about the position adopted by the covalently linked ubiquitin
with respect to Josephin. We produced samples in which 15N-
labeled JosK117-only was covalently linked to unlabeled ubiquitin
or 15N-labeled ubiquitin was linked to unlabeled JosK117-only.
This allowed individual analysis of the changes occurring on
each of the two proteins upon formation of the isopeptide
bond.
As previously reported, ubiquitination leads to significant
variations of the 15N HSQC spectrum of JosK117-only (Faggiano
et al., 2013). Nevertheless, 65% of the amide peaks have CSP val-
ues lower than 0.05 ppm, indicating that overall the tertiary struc-
ture of Josephin is conserved after ubiquitination (Figure 1A).
This conclusion was independently confirmed by far-UV CD: the
spectrum of mono-ubiquitinated JosK117-only superimposes to
the arithmetical sum of the spectra of JosK117-only and of free
ubiquitin (Figure 1B), indicating that the secondary structure of
the protein remains the same after mono-ubiquitination.
The majority of residues with larger CSP values reside between
residues 40–80 and map on/near the α2/α3 helical hairpin.
Cross-saturation data confirmed this pattern (Figure 1C). The
residues mostly affected include the second half of helix α2, which
extends away from the globular core of Josephin, the loop between
helix α2 and α3, helix α3, and the long loop between helices α3
and α4 Large CSP values are also present for residues S76, I77,
Q78, and S81, all of which are in site 1. In addition, ubiquitina-
tion affects the amide resonance of the catalytic cysteine (C14)
which shifts from 9.24 to 9.05, whereas the nitrogen resonance
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Figure 1 | Mapping ubiquitination on the Josephin surface. (A) Chemical
shift perturbation of the changes occurring on 15N labeled Josephin domain
after ubiquitination of JosK117-only. (B) Far-UV CD spectra of JosK117-only
(blue), mono-ubiquitinated JosK117-only (green), ubiquitin (yellow). The
arithmetical sum of the spectra of JosK117-only and of free ubiquitin is
reported in dashed cyan. (C) Cross-saturation experiment on perdeuterated
15N JosK117-only covalently attached to unlabeled ubiquitin on K117. (D) 15N
HSQC spectra for the C14 peak before (blue) and after (green) ubiquitination.
experiences only a minor shift (from 119.1 ppm to 119.0 ppm)
(Figure 1D). In contrast, the amide resonances of the other two
residues of the catalytic triad (H119 and N134) remain mostly
invariant as does Q9, the residue proposed to form the oxyanion
hole (Weeks et al., 2011). Interestingly, C14, like other residues
close to it (i.e., E7, S12, Q16, H17, and C18), has weak peaks
in the 15N HSQC spectra of wild-type Josephin, JosK117-only
and ubiquitinated JosK117-only. This result suggests that the cat-
alytic cysteine and residues around it are in a conformational
exchange and that ubiquitination directly influences the chemi-
cal environment of residues in this region. Since CSP indicates
perturbation of the chemical environment caused by an inter-
action but not necessarily a direct interface, we also performed
cross-saturation experiments to map surfaces in direct contact
(Takahashi et al., 2000). The experiment carried out on perdeuter-
ated 15N JosK117-only covalently linked to unlabeled ubiquitin
confirmed that the residues involved in the interface with ubiq-
uitin are K117, residues of site 1 and residues of helix α2 in the
flexible helical hairpin (Figure 1C). The second helix forming the
hairpin (helix α3) does not appear to be directly involved in the
interaction. In addition, residues on the flexible loop between
helix α3 and helix α4 such as G67 and D70 are at the interface
with ubiquitin.
The effect of ubiquitination on the dynamics of residues in or
near site 1 is also evident from the NMR relaxation experiments.
Ubiquitination induces a clear stiffening of the motions around
the helical hairpin, as observed from the drastic change of T1, T2
and NOE values for residues of the hairpin (residues 30-75). In
isolated JosK117-only, the T1 values and heteronuclear NOEs are
significantly lower and T2 values higher than average (Figure 2),
pointing to greater flexibility. In ubiquitinated JosK117-only,
the motions of the hairpin change markedly revealing a dimin-
ished flexibility with respect to the non-ubiquitinated protein. A
comparable effect was previously reported when comparing free
Josephin to Josephin non-covalently bound to ubiquitin (Nicastro
et al., 2009) confirming that covalently linked and free ubiquitins
bind in a similar way in site 1.
Estimate of the correlation times, as calculated from the aver-
age NMR T1/T2 ratios (i.e., excluding residues 30–75), shows an
increase from a value of 12.6 ns for isolated 15N JosK117-only
(to be compared with 11.7 ns for wild-type Josephin (Nicastro
et al., 2005) to a value of 16.5 ns for the mono-ubiquitinated
protein. This result is in agreement with the value expected for
a globular protein of the size comparable to the complex that
tumbles isotropically (Maciejewski et al., 2000).
Together, these results indicate that covalently linked ubiquitin
occupies site 1.
K117-LINKED UBIQUITIN BINDS TO JOSEPHIN THROUGH ITS
HYDROPHOBIC PATCH CENTERED ON I44
To determine the orientation of ubiquitin in the covalent
complex,15N ubiquitin was in turn covalently linked to unlabeled
JosK117-only. As observed above for Josephin, the 15N HSQC
spectrum of labeled ubiquitin changes significantly when it inter-
acts with unlabeled Josephin (Faggiano et al., 2013). The residue
with the largest CSP value is G76, as expected for covalent mod-
ification via this residue. Large CSP values are also observed for
G47, L48, V70, and L71 (Figure 3A). Significant changes occur
also for residues close in sequence to L8 and I44. The CSP pro-
file is similar to that obtained after binding of free 15N ubiquitin
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Figure 2 | Comparison of T1, T2, heteronuclear NOE relaxation
experiments for 15N JosK117-only (blue) and its mono-ubiquitinated
form (green).
to site 1 of Josephin in the W87K mutant which silences site 2
(Nicastro et al., 2009). The residues involved in the interface, with
the exception of G76, lay on the hydrophobic surface of ubiquitin
centered on I44.
To further substantiate our results, we measured the dynam-
ical parameters of covalently-linked ubiquitin (Figure 3B). The
correlation time calculated from the average T1/T2 ratio is 15.2
ns, in excellent agreement with that calculated for labeled mono-
ubiquitinated JosK117-only and appreciably larger than that
expected for free ubiquitin (4.1 ns, Schneider et al., 1992). These
results confirm that the two molecules tumble together in solu-
tion as a compact globular assembly.
Taken together, the NMR data indicate that the cova-
lently linked ubiquitin interacts with JosK117-only through
the canonical exposed hydrophobic patch formed by L8, I44,
and V70.
INTERMOLECULAR NOEs CONFIRM THAT SITE 1 IS AT THE INTERFACE
WITH UBIQUITIN
To substantiate further the chemical shift perturbation and cross
saturation data, we acquired a 3D 15N-edited NOESY-HSQC
on mono-ubiquitinated JosK117-only (having the Josephin
Figure 3 | Mapping ubiquitination on the ubiquitin surface. (A)
Chemical shift perturbation of the changes occurring on 15N ubiquitin after
covalent linkage with JosK117-only. (B) T1, T2, heteronuclear NOE relaxation
experiments for 15N ubiquitin covalently linked to JosK117-only (dark green).
moiety 2H,15N labeled linked to unlabeled ubiquitin) to obtain
intermolecular distance restraints. Perdeuteration of JosK117-
only resulted crucial to obtain intermolecular NOEs. In contrast,
filtered 15N- or 13C-editedNOESY-HSQC experiments on labeled
JosK117-only linked to unlabeled ubiquitin were unsuccessful due
to low sensitivity (they only confirmed attachment of ubiquitin to
K117). The high level of deuteration of the sample was controlled
by monodimensional proton NMR, ruling out the possibility
of observing Josephin intramolecular NOEs in the 15N-edited
NOESY-HSQC (data not shown). We observed a number of
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Figure 4 | 2D projection of the 15N-edited NOESY-HSQC in the H-Hind dimension showing the quality of the observed intermolecular NOE effects.
Table 1 | List of AIRs, NOEs and other restraints used for the docking with HADDOCK.
AIRs NOEs between Jos backbone amides
and ubiquitin side chains
Jos K117-ubiquitin G76 linkage Fully flexible segments
Jos: 43, 44, 47, 48, 50, 51, 67,
70, 77, 78, 93, 117
Ub: 6, 8, 10, 11, 12, 34, 35,
46, 47, 49, 71, 76
(69, 70, 76, 77)–(3 or 44)a
(43, 44, 45, 77, 78)–(8 or 70)
(81, 82)–(9 or 44)
distance restraint between Jos K117
Nε and ubiquitin G76 carboxyl
Jos 52–75 ubiquitin 72–76
cross-saturation (Jos)
CSP (ubiquitin)
15N edited NOESY-HSQC Mass spectrometry, NMR NMR relaxation experiments
In the second row are listed the effects observed, in the third the technique by which they have been obtained. JosK117-only is abbreviated as Jos.
a The initial assignment ambiguities were resolved at the end of the calculations with the selection of only one possible assignment. This excluded I3 and V70.
intermolecular NOE effects (Figure 4). The assignment of the
residues of Josephin involved is unambiguous: the effects corre-
spond to the Josephin amide protons of E43, E44, R45, M69, D70,
S76, I77, Q78, S81, and N82. Assignment of the ubiquitin reso-
nances has some ambiguity but all refer to side chain aliphatic
protons of residues that, except for I3, reside in the I44 hydropho-
bic patch confirming that, for ubiquitin covalently linked to K117,
this surface is involved in additional non-covalent binding to
Josephin (Table 1).
These results thus confirm that site 1, helix α2, and the loop
between α3 and α4 are at the interface with ubiquitin.
MODELING THE STRUCTURE OF THE COMPLEX
We modeled ubiquitinated JosK117-only on the basis of NMR
CSP, cross-saturation data and intermolecular NOEs (Table 1
and Figures 5A,B). The NOE-based distances, which involve
unambiguous Josephin resonances but ambiguous ubiquitin res-
onances, were inserted as ambiguous restraints allowing the pro-
gram to discriminate between the possible assignments for each
ubiquitin resonance. The distances were all uniquely assigned to
a specific ubiquitin group during the iterative procedure. The
final solutions can be grouped in two similar clusters of struc-
tures, one of which is statistically predominant (>75% of the
structures) and is significantly better in terms of overall energy,
HADDOCK score and restraint violations (Table 2). The inter-
molecular NOE restraints (distance ranging from 2.0 to 6.0 Å)
were satisfied in all structures of cluster 1. The relative orientation
of the two molecules and the position of ubiquitin in the model
Table 2 | Statistics for the analysis of the structures of the covalent
complex calculated by HADDOCK.
Critera Cluster 1 Cluster 2
HADDOCK score −133.4± 5.2 −86.6± 3.1
Cluster size 160 40
RMSD from lowest-energy structure 1.5± 0.9 8.8± 0.9
Van der Waals energy −80.8± 6.2 −88.0± 5.5
Electrostatic energy −468.0± 19.0 −270.0± 61.7
Desolvation energy 40.1± 3.8 26.7± 7.0
Restraints violation energy 9.3± 11.4 286.5± 106.39
Buried Surface Area 2602.8± 69.3 2395.7± 67.3
Z-score −1.0 1.0
(Figure 5C, left) are remarkably similar to that of the crystal
structure of the ataxin-3 like protein ATXN3L covalently ubiq-
uitinated on the active site C14 (Figure 5C, center) (Weeks et al.,
2011) despite the different and independent approaches adopted
to obtain the structures. The only main differences are the posi-
tion of the flexible loop between helix α3 and α4 in ataxin-3
and the orientation of the ubiquitin C-terminus: the loop moves
toward the covalently linked ubiquitin. In the X-ray structure of
ATXN3L, the C-terminus of ubiquitin is covalently attached to
C14 and, to reach this side chain, inserts in between the back-
bone atoms of F74 and E118. In themodel of mono-ubiquitinated
JosK117-only, the C-terminus is rotated by approximately 45
degrees to reach the more exposed side chain of K117 that
Frontiers in Molecular Biosciences | Structural Biology February 2015 | Volume 2 | Article 2 | 6
Faggiano et al. The structure of ubiquitinated ataxin-3
Figure 5 | Restraints used in the calculation and resulting structure. (A)
Mapping the cross saturation effects and CSP on the structures of Josephin
and ubiquitin, respectively. The color coding used is the following: cross
saturation on Josephin is indicated in red and orange for values of attenuation
>30% and 10–30%, respectively. Values of CSP >0.3 ppm and 0.1–0.3 ppm
are marked in red and orange on the surface of ubiquitin. (B) Mapping
intermolecular NOE effects between JosK117-only and ubiquitin on the best
HADDOCK model in terms of energy and restraint violations. In yellow are
shown the side chains of the ubiquitin residues selected in the calculation
(L8, T9, I44). In red are marked the involved (unambiguous) JosK117-only
residues. (C) Comparison of the model of mono-ubiquitinated JosK117-only
obtained using the software HADDOCK (left) with the crystal structures of
the Josephin-like domain from ATXN3L (center, 3O65) and of the DUB
UCH-L3 (right, 1XD3), both linked to ubiquitin by the catalytic cysteine
(explicitly indicated). The structure of the UCH-L3/ubiquitin assembly is
thought to mimic that of the reaction intermediate and suggests that, despite
specific differences, ubiquitin binds DUB enzymes adopting approximately
equivalent orientations as respect to the catalytic triads.
is situated in the main sub-domain on a β-hairpin above the
active site. Other differences may well be within the resolution
of the HADDOCK model. Interestingly, the mode of interaction
also broadly agrees with other DUB complexes with ubiquitin
(Figure 5C, right).
These results indicate that the overall modality of interac-
tion with ubiquitin is independent from the specific anchoring
mode.
It is also important to notice that, in the model of mono-
ubiquitinated Josephin, the residues of the catalytic triad (C14,
H119, and N134) are exposed to the solvent, hence still available
for the recognition and binding of the isopeptide bond in the sub-
strate. Therefore, the covalent binding of ubiquitin on K117 and
the non-covalent coordination to site 1 do not impair the access
of the substrate cleavable group to the active site.
COVALENT UBIQUITINATION COMPETES WITH FREE UBIQUITIN FOR
BINDING TO SITE 1
To determine if the surface around site 1 is still available for sub-
strate binding in ubiquitinated Josephin, we titrated 15N-labeled
JosK117-only covalently linked to unlabeled ubiquitin with free
ubiquitin. As a control, non-ubiquitinated 15N-labeled JosK117-
only was titrated with free ubiquitin. In the 15N HSQC spectra,
the resonances of residues in site 2, centered on W87, move upon
addition of ubiquitin for both JosK117-only and its ubiquitinated
form (Figure 6A, top). The estimated affinity constants for ubiq-
uitin binding to site 2 are 330 and 220μM for JosK117-only and
its ubiquitinated form, respectively. The two values are compara-
ble within experimental error, given the relatively low affinities.
These results confirm that ubiquitination does not influence the
availability of site 2, consistent with a previous report (Todi et al.,
2010).
We observe very different results for residues in site 1 and the
α2/α3 helical hairpin (i.e., I77, Q78, S81,G51, G52, T54, T60,
and Q64). In JosK117-only, the resonances of these residues
broaden to disappearance upon titration with ubiquitin, indi-
cating that they are in an intermediate exchange regime. The
same resonances are much less affected by titration with free
ubiquitin in the spectra of mono-ubiquitinated JosK117-only
(Figure 6A, center and bottom). This confirms that, in the
mono-ubiquitinated protein, the helical hairpin is less readily
available for binding free ubiquitin, in agreement with site 1
already being occupied.
We then titrated 15N ubiquitin with an unlabeled W87R
mutant of JosK117-only (JosK117-onlyW87R) which markedly
impairs ubiquitin binding to site 2 (Nicastro et al., 2009). This
www.frontiersin.org February 2015 | Volume 2 | Article 2 | 7
Faggiano et al. The structure of ubiquitinated ataxin-3
Figure 6 | Testing the effects of ubiquitination on lysine 117 by NMR. (A)
Titration of 15N JosK117-only (left, from light to dark blue) and of
mono-ubiquitinated JosK117-only obtained using 15N labeled Josephin (right,
from light to dark green) with free ubiquitin. Residues shown are Y27 (top),
I77 (center) and G51 (bottom). (B) Titration of 15N ubiquitin (yellow) with
JosK117-only W87R mutant (blue) and its mono-ubiquitinated form (green).
The color scheme is indicated with a cartoon of the proteins colored to match
the spectra.
way, we could monitor only the chemical shift variations on 15N-
labeled ubiquitin caused by binding to site 1. The CSP plot after
addition of two equivalents of JosK117-onlyW87R confirmed that
the interface involved in binding is the canonical I44 patch, con-
firming what we previously reported (Nicastro et al., 2010). The
peaks corresponding to G47 and D32 disappear. Other peaks,
including L8, I13, K48, V70, L71, and L73, shift. Addition of the
same equivalents of unlabeled ubiquitinated JosK117-onlyW87R
induced much smaller chemical shift variations (Figure 6B). This
can be explained by a decreased affinity for recognition of ubiq-
uitin in ubiquitinated Josephin.
Taken together, these data indicate that covalently linked ubiq-
uitin competes with free ubiquitin, reducing its ability to bind to
site 1.
VALIDATION OF THE MONO-UBIQUITINATED JosK117-ONLY MODEL BY
SAXS
We independently validated the structure of the mono-
ubiquitinated JosK117-only complex by SAXS. We acquired data
for isolated JosK117-only and for the complex (Figure 7A). The
estimated apparent molecular mass (MMexp) and hydrated par-
ticle volume (Vp) for JosK117-only tightly reproduced previous
datasets collected for wild-type Josephin (Nicastro et al., 2006).
The MMexp and Vp of the mono-ubiquitinated JosK117-only
complex are distinctly different from those of the isolated species:
the estimated molecular mass (MMexp = 26 ± 3 kDa) and
hydrated particle volume (Vp = 48 ± 4 nm3) clearly corresponds
to the 1:1 stoichiometry of the complex.
The ab initio and rigid body modeling of the mono-
ubiquitinated JosK117-only data yielded consistent shapes
(Figure 7B). At the same time our HADDOCK model
(Figure 7B) provides the fit of similar quality as the rigid
body model (Figure 7A, chi value 1.14) and overlaps with the ab
initio shape. The orientation of the ubiquitin molecule relative
to the Josephin domain in the rigid body model of course differs
from that of the HADDOCK model. This is not surprising as no
contact restraints were applied during the rigid body modeling.
The fact that the positions of the ubiquitin molecule in both
models are matching each other, clearly and independently
endorses that the K117 covalently bound ubiquitin is positioned
in site 1.
JOSEPHIN IS ALSO ACTIVATED BY NON-COVALENTLY BOUND
UBIQUITIN
The observation that mutations at site 1 abolish enzymatic activ-
ity, together with the structural data reported here on K117
mono-ubiquitinated Josephin, suggest that ubiquitin bound to
site 1 behaves as a conformational switch that brings the protein
into an activated state that can only be reached when site 1 is occu-
pied. Based on our results, the role of ubiquitin in site 1 is not
that of hosting the substrate but rather of locking the protein into
an active conformation. This model predicts that free ubiquitin
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Figure 7 | SAXS data recorded on mono-ubiquitinated JosK117-only.
(A) The experimental raw data are shown in blue. Fit with our HADDOCK
lowest energy model is indicated by a red line. (B) The lowest energy
HADDOCK model of mono-ubiquitinated JosK117-only (shown as green and
red carbon alpha traces) and the rigid body model (green and yellow traces)
superimposed with the averaged ab initio bead model (gray spheres). The
right view is rotated 90◦ counterclockwise.
also could have an activating effect. To validate this prediction, we
probed the effect of ubiquitin on the Josephin enzymatic activ-
ity using a fluorimetric assay employing Ub-AMC, a ubiquitin
derivative in which a fluorescent probe is attached to the protein
C-terminus (Dang et al., 1998). The fluorescence assay allowed
us to quantify for the first time the degree of activation due to
mono-ubiquitination.
As a preliminary control, we compared the DUB activity
of wild-type Josephin, JosK117-only and mono-ubiquitinated
JosK117-only. The mutant JosK117-only has a behavior indis-
tinguishable from wild-type Josephin confirming that mutations
eliminating all other lysines in the protein do not affect the enzy-
matic activity. We detected a ∼7-fold increase in the cleavage
rate of Ub-AMC for mono-ubiquitinated Josephin (Figure 8A).
Covalent mono-ubiquitination activates Josephin also toward
cleavage of K48- and K63-linked di-ubiquitin (Figure 9). As with
Ub-AMC, cleavage is anyway very ineffective: equimolar concen-
trations of enzyme and substrate are required to observe the activ-
ity. However, the evidence thatmono-ubiquitination increases the
activity not only toward longer ubiquitin chains (Todi et al., 2010)
but also toward smaller substrates suggests that there is a com-
mon mechanism of activation, independent from the length of
the substrate.
As a positive control to ensure that the observed low activ-
ity is not due to the conditions of our assay, we compared the
Josephin activity with that of another well characterized DUB,
isopeptidase T. We had to use ten-fold higher enzyme/substrate
molar ratios to observe cleavage by Josephin (10 nM isopepti-
dase T versus 100 nM Josephin were used to cleave 1μM Ub-
AMC). Concentrations 10 times lower of isopeptidase T produce
a much stronger effect, demonstrating how ineffective Josephin
is on this substrate (Figure 8B). Accordingly, it was previously
reported that Ub-AMC is unsuitable for rigorous Michaelis-
Menten kinetic studies of Josephin as its enzymatic Km value
exceeds its solubility (Weeks et al., 2011).
Finally, we probed the activity of JosK117-only at increasing
concentrations of non-covalently attached ubiquitin (Figure 8C).
The presence of a large excess of free ubiquitin (at concentrations
ranging from 1000 to 40000 fold with respect to the substrate
Ub-AMC) induced activation toward Ub-AMC cleavage. The
effect becomes stronger with increasing concentrations of ubiq-
uitin and reaches a plateau, indicating specific binding of free
ubiquitin to Josephin. The addition of 2mM ubiquitin induced
a ∼56-fold increase of the activity of JosK117-only. Mutation
of site 2 (W87R) does not influence the effect (Figure S1 of
Supplementary Materials), pointing to a crucial role of site 1
in the activation mechanism. On the contrary, mutation of
site 1 (I77R/Q78R) impairs completely Ub-AMC cleavage, also
in the presence of free ubiquitin (Figure S2 of Supplementary
Materials). These data confirm our model and indicate that
binding of ubiquitin to site 1 contributes to the activation of
Josephin, supporting the idea that mono-ubiquitinated Josephin
has enhanced activity due to the binding of the covalently linked
ubiquitin to site 1.
Rather surprisingly, we observed a similar effect also with
mono-ubiquitinated JosK117-only at increasing concentrations
of non-covalently attached ubiquitin (Figure 8D). The addition
of 2mM ubiquitin caused a 6-fold increase of the rate of cleav-
age of Ub-AMC by mono-ubiquitinated JosK117-only. We can
exclude the presence of significant contamination of the sam-
ple with unmodified protein that could explain this effect: the
ion exchange purification protocol allows the separation of the
two components of the ubiquitination mixture (Faggiano et al.,
2013). A possible explanation is that, given the large excess of
free ubiquitin added, free ubiquitin is able to displace the cova-
lently linked ubiquitin and produce an activation effect because
of the increasingly effective concentration of ubiquitin. In alter-
native, it is possible that Josephin could host other ubiquitin
binding sites with very low affinity (millimolar range) which
could be responsible for the effect of free ubiquitin on the activ-
ity of the enzyme. We plan to investigate this point further. Raw
data for the kinetics are reported in Figure S3 of Supplementary
Materials.
DISCUSSION
Understanding how DUB enzymes work and are regulated
is of great interest if we wish to gain insights into the
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Figure 8 | Effect of ubiquitin on the enzymatic kinetics. (A) Comparison of
the cleavage rate of ubiquitin-AMC (expressed in relative fluorescence units
per minute) by wild-type Josephin, JosK117-only, and mono-ubiquitinated
JosK117-only. (B) Comparison of the cleavage rate of JosK117-only and
mono-ubiquitinated JosK117-only with that of another typical DUB,
isopeptidase T, at a concentration 10 times lower. (C,D) Enzymatic activity
respectively of JosK117-only and mono-ubiquitinated JosK117-only in the
presence of increasing concentrations of free ubiquitin.
Figure 9 | Cleavage of K48 (left) and K63 (right) linked di-ubiquitin by JosK117-only and its mono-ubiquitinated form. The faint bands are impurities
likely from small amounts of di-ubiquitinated protein that became visible because of prolonged (overnight) staining with InstantBlue (Expedeon).
complexity of the ubiquitin code. Ataxin-3 is a particu-
larly interesting DUB because it plays a central role in a
neurodegenerative disease, interacts with multiple ubiq-
uitin ligases, and regulates ubiquitin chain production
and proteasomal degradation of proteins (Matos et al.,
2011). As compared to other DUB enzymes, ataxin-3 also
possesses unusual enzymatic properties including low intrinsic
activity.
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Here, we have studied how ubiquitination of K117 affects
the Josephin domain and investigated the mechanism that leads
to the previously described activation of ataxin-3 (Todi et al.,
2009, 2010). Ubiquitination of Josephin is a stable modification
as previously showed: ubiquitinated ataxin-3 is stable overnight
and unmodified ataxin-3 is unable to deubiquitinate catalytically
inactive ubiquitinated ataxin-3 (Todi et al., 2009, 2010). These
data suggest that other DUBs may revert this post-translational
modification. It will be interesting to determine how this regula-
tory cycle comes to completion.
In principle, mono-ubiquitination could lead to two possi-
ble scenarios: the covalently attached ubiquitin could be flexible
or pack against Josephin. We demonstrated that ubiquitination
of K117 does not influence the overall structure of the Josephin
domain and that the covalently linked ubiquitin sits in site 1,
adopting a structure very similar to that observed in the crys-
tal structure of a closely related Josephin covalently attached
to ubiquitin through the catalytic C14 cysteine (Weeks et al.,
2011). The linkage between K117 and ubiquitin is in a position
equivalent to that observed in this structure. This conclusion is
strongly supported by CSP, the more direct cross-saturation and
NOE data and by SAXS. We observed chemical shift perturba-
tion very similar to that observed when adding free ubiquitin to
Josephin (Nicastro et al., 2009). We could rule out intermolecu-
lar effects by measuring the correlation time which corresponds
to a species of ∼30 kDa, a molecular weight that is compatible
with the monomeric complex. Any other scenario would appre-
ciably increase the correlation time. Intramolecular rather than
intermolecular effects between two covalently linked chains are
also expected from the well accepted knowledge that linking two
chains favors their direct interaction and significantly increases
the chances of their encountering for entropic reasons. This con-
cept is for instance widely used in drug design (Harner et al.,
2013). In further support of our conclusions is the observation
that occupancy of site 1 by the covalently attached ubiquitin
results in a reduction of the hairpin flexibility similar to what
was previously observed by NMR and molecular dynamics stud-
ies upon binding of non-covalently bound ubiquitin (Nicastro
et al., 2009). Together, these observations cannot be explained dif-
ferently than by concluding that the covalently bound ubiquitin
occupies site 1 of Josephin.
In light of these new data, we propose a revised role for site 1
in ataxin-3 DUB activity: contrary to our previous belief, instead
of or in addition to binding the ubiquitin substrate and “coordi-
nating” it for attack by the catalytic triad, occupation of site 1 by
mono-ubiquitin “locks” the catalytic domain into an activemode.
Ataxin-3 thus provides a novel example of enzyme regulation
in which the interaction of the substrate with a substrate-binding
site distinct from the catalytic site functions as a regulatory switch.
This implies a feedback regulation of this enzyme in which the
substrate is at the same time an allosteric regulator. Regulation
of DUB activities by their binding to ubiquitin has been reported
for other such enzymes (e.g., USP7) (Hu et al., 2002). However,
the regulatory mechanism supported by our current findings has
not been described before for a protease. Our observations fit
well also with the suggestion put forward by Komander and col-
leagues that ubiquitination could allosterically regulate protein
function (Komander, 2009; Komander et al., 2009). Another
example of such a mechanism is the activation of cullin SCF
ligases by NEDDylation (Duda et al., 2008). In this case, acti-
vation is caused by a conformational change that locks this E3
ubiquitinating enzyme into an active conformation. We predict
that more such examples will be found, progressively revealing
the complexmodalities by which post-translational modifications
mediate enzyme regulation.
A possible explanation of our findings and given that, when
silencing site 2, mono-ubiquitinated Josephin remains enzymati-
cally as active as the wild-type protein, is that the domain could
contain a third yet unidentified ubiquitin binding site. The addi-
tional site could bind ubiquitin more weakly than site 1 and
2 since no obvious evidence of it was found in our titrations
of Josephin with mono-ubiquitin (Nicastro et al., 2005, 2010).
This hypothesis would explain why Ub-AMC and di-ubiquitin
are such poor substrates for ataxin-3 (Burnett and Pittman, 2005;
Winborn et al., 2008). It would also not be unusual: the affini-
ties of several isolated UBDs with mono-ubiquitin are weak, with
dissociation constants >100μM (Reyes-Turcu and Wilkinson,
2009). Yeast OTU1, for instance, shows no binding up to 2mM
ubiquitin while UCH-L3 binds ubiquitin with an affinity of
100–500μM. As in other DUBs, the affinity of ataxin-3 will be
increased by avidity thanks to the multiple binding sites, thus
explaining the need of such redundancy. This third ubiquitin
binding site, being rarely populated if at all when site 1 is not
ubiquitinated, would become populated and active only when site
1 is occupied. Ubiquitin binding to site 1 could be completely
ineffective or, perhaps more likely, less effective than the alterna-
tive site leading to the observed low enzymatic activity with small
substrates.
It was previously shown that specific, engineered Josephin
mutations also result in enzyme activation (Weeks et al., 2011).
These mutations were generated based on the observation that
the ataxin-3 like protein ATXN3L is a significantly more effi-
cient enzyme than ataxin-3, despite the two proteins sharing
85% sequence identity. As few as three mutations, namely S12F,
R59L, and T60A, are sufficient to increase the catalytic activ-
ity of ataxin-3 to levels comparable to that of ATXN3L. We can
suggest an explanation for these results based on our findings:
as mentioned in the original account, S12 is close to the cat-
alytic C14 and, together with F74, may form a hydrophobic lid
of the active site. It was argued that the S12F mutation could
result in activation by enhancing the nucleophilicity of the active
site cysteine and/or enhancing affinity for substrate (Weeks et al.,
2011). In support to this hypothesis, we observe that S12 is in a
conformational exchange and that ubiquitination influences its
environment (i.e., different chemical shift). The other two muta-
tions thatmarkedly enhance ataxin-3 activity, R59L and T60A, are
far from the catalytic site and in the middle of helix α3. Because
these residues point far away from the interface with ubiquitin
and make no direct contact with ubiquitin in the crystal struc-
ture, it was suggested that the mode of ubiquitin recognition in
ATXN3L and ataxin-3 could be slightly different. Based on our
data, we suggest instead that the mutations could affect the hair-
pin flexibility thus producing effects equivalent to those obtained
by mono-ubiquitination.
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In conclusion, the data presented in this work offer a new
model of the mechanisms governing the catalytic activity of
ataxin-3 and indicate the importance of identifying and charac-
terizing further the multiple binding properties of this unusual
DUB enzyme. Efforts along this line are currently in progress in
our group.
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Figure S1 | Effects of the addition of free ubiquitin to JosK117-only W87R
and JosK117-only I77R/Q78R, respectively.
Figure S2 | Effects of the addition of free ubiquitin to JosK117-only W87R
and JosK117-only I77R/Q78R, respectively.
Figure S3 | Raw data for the kinetics of Ub-AMC cleavage as in Figure 8.
(A) Comparison of the cleavage rate of ubiquitin-AMC by wild-type
Josephin (light blue), JosK117-only (blue), and mono-ubiquitinated
JosK117-only (green). In black, a control is run without Josephin in the
mixture. (B) Comparison of the cleavage rate of JosK117-only (blue) and
mono-ubiquitinated JosK117-only (green) with that of another typical DUB,
isopeptidase T (magenta). (C,D) Cleavage of Ub-AMC by respectively
JosK117-only and mono-ubiquitinated JosK117-only in the presence of
increasing concentrations of free ubiquitin. The coordinates of the model
structure of mono-ubiquitinated JosK117-only can be found online at:
https://bioinformatics.cineca.it/PMDB/main.php as “K117
mono-ubiquitinated Josephin domain of ataxin-3.”
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